Gel and Capillary Electrophoresis Compared for Human Proteins
By LabMedica International staff writers Posted on 12 May 2021 |

Image: The Capillarys 3 TERA is an automated analyzer based on capillary zone electrophoresis and UV detection for the quantitative analysis of Hba1c, proteins (serum and urine), immunotyping (serum and urine), and carbohydrate deficient transferrin (Photo courtesy of Sebia)
The electrophoresis of serum proteins remains a laboratory cornerstone for the diagnosis and monitoring of patients with plasma cell disorders, such as monoclonal gammopathy of undetermined significance, multiple myeloma, Waldenström macroglobulinemia, and AL amyloidosis.
Gel electrophoresis remains the method used by most clinical laboratories in the USA. However usage of gel electrophoresis is gradually decreasing while that of capillary electrophoresis is increasing. More recently, analysis of liquid media by capillary electrophoresis was developed and applied to the analysis of serum proteins for clinical purposes.
Laboratory Immunologists at The Johns Hopkins School of Medicine (Baltimore, MD, USA) tested all serum samples analyzed by the immunology laboratory over the course of eight days for routine clinical purposes during the months of October and November 2019, totaling 304 sera. There were 160 females (62 ± 16 years, range 19 -95) and 144 males (65 ± 14 years, range 23-97), with no significant difference in age according to sex.
Sera were first ran using the system currently in use, which consists of a thin-layer agarose gel, HYDRAGEL 30 Protein (E) (Sebia, Lisses, France) and the Sebia Hydrasys 2 semi-automated analyzer. Sera were then assayed on the Sebia Capillarys III TERA automated analyzer using CAPI 3 Protein (E) reagents. Serum immunofixation electrophoresis (SIFE) was performed in 214 of the total 304 sera because already ordered by the provider for most cases. Sera were pre-diluted according to the immunoglobulin G, A, and M concentrations, and then ran on the immunofixation system currently in use, which consists of a thin-layer agarose gel (HYDRAGEL IF 2/4, from Sebia) and the Hydrasys 2 semi-automated analyzer.
The scientists reported that Gel and capillary estimated the concentration of albumin, gamma region, and M-spikes nearly perfectly, and that of beta, alpha-2, and alpha-1 regions with excellent correlation. The two systems classified concordantly 268 of 304 sera (88% agreement) as having no, one, or two M-spikes, but differed in the remaining 36 sera (12%). Gel electrophoresis correctly identified M-spikes in 82 of 112 sera that were shown to have monoclonal band(s) by immunofixation (73% sensitivity), and correctly did not reveal M-spikes in 97/102 sera that had no immunofixation bands (95% specificity). Capillary achieved slightly higher sensitivity (85/112, 76%) and slightly lower specificity (94/102, 92%), but the two areas under the ROC curves were nearly identical at 0.84.
The authors concluded that Gel and capillary electrophoresis systems perform similarly to estimate the concentration of serum protein fractions and detect M-spikes. The Capillarys system has the disadvantages of a higher equipment cost and requiring a greater sample volume. On the other hand, Capillarys requires less involvement of laboratory technicians, offers a faster turn-around time, identifies the specimens they are being analyzed, does not depend upon the chemicals needed to stain and destain the gels, and is more amenable to remote reporting. The study was published on April 29, 2021 in the journal Practical Laboratory Medicine.
Related Links:
The Johns Hopkins School of Medicine
Sebia
Gel electrophoresis remains the method used by most clinical laboratories in the USA. However usage of gel electrophoresis is gradually decreasing while that of capillary electrophoresis is increasing. More recently, analysis of liquid media by capillary electrophoresis was developed and applied to the analysis of serum proteins for clinical purposes.
Laboratory Immunologists at The Johns Hopkins School of Medicine (Baltimore, MD, USA) tested all serum samples analyzed by the immunology laboratory over the course of eight days for routine clinical purposes during the months of October and November 2019, totaling 304 sera. There were 160 females (62 ± 16 years, range 19 -95) and 144 males (65 ± 14 years, range 23-97), with no significant difference in age according to sex.
Sera were first ran using the system currently in use, which consists of a thin-layer agarose gel, HYDRAGEL 30 Protein (E) (Sebia, Lisses, France) and the Sebia Hydrasys 2 semi-automated analyzer. Sera were then assayed on the Sebia Capillarys III TERA automated analyzer using CAPI 3 Protein (E) reagents. Serum immunofixation electrophoresis (SIFE) was performed in 214 of the total 304 sera because already ordered by the provider for most cases. Sera were pre-diluted according to the immunoglobulin G, A, and M concentrations, and then ran on the immunofixation system currently in use, which consists of a thin-layer agarose gel (HYDRAGEL IF 2/4, from Sebia) and the Hydrasys 2 semi-automated analyzer.
The scientists reported that Gel and capillary estimated the concentration of albumin, gamma region, and M-spikes nearly perfectly, and that of beta, alpha-2, and alpha-1 regions with excellent correlation. The two systems classified concordantly 268 of 304 sera (88% agreement) as having no, one, or two M-spikes, but differed in the remaining 36 sera (12%). Gel electrophoresis correctly identified M-spikes in 82 of 112 sera that were shown to have monoclonal band(s) by immunofixation (73% sensitivity), and correctly did not reveal M-spikes in 97/102 sera that had no immunofixation bands (95% specificity). Capillary achieved slightly higher sensitivity (85/112, 76%) and slightly lower specificity (94/102, 92%), but the two areas under the ROC curves were nearly identical at 0.84.
The authors concluded that Gel and capillary electrophoresis systems perform similarly to estimate the concentration of serum protein fractions and detect M-spikes. The Capillarys system has the disadvantages of a higher equipment cost and requiring a greater sample volume. On the other hand, Capillarys requires less involvement of laboratory technicians, offers a faster turn-around time, identifies the specimens they are being analyzed, does not depend upon the chemicals needed to stain and destain the gels, and is more amenable to remote reporting. The study was published on April 29, 2021 in the journal Practical Laboratory Medicine.
Related Links:
The Johns Hopkins School of Medicine
Sebia
Latest Immunology News
- Blood Test Detects Organ Rejection in Heart Transplant Patients
- Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
- Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
- New Tool Detects Breast Cancer Relapses Five Years in Advance
- T Cells in Blood Can Detect Parkinson's Years Before Diagnosis
- POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood
- Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients
- First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop
- Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
- Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
- Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
- Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
- New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
- Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
- Novel Analytical Method Tracks Progression of Autoimmune Diseases
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
Blood Test Could Predict Likelihood of Breast Cancer Spreading to The Bone
When breast cancer spreads to other parts of the body, it becomes secondary or metastatic breast cancer—a stage that, while treatable, is currently incurable. The bone is the most common site for this... Read more
New Infectious Disease Analytics Platform Speeds Up Clinical Decision-Making at POC
During the COVID-19 pandemic, the importance of accurate and timely interpretation of diagnostic data became evident in shaping both public health strategies and clinical outcomes. As the world now grapples... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Performs Virtual Tissue Staining at Super-Resolution
Conventional histopathology, essential for diagnosing various diseases, typically involves chemically staining tissue samples to reveal cellular structures under a microscope. This process, known as “histochemical... Read more
AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis
Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read moreTechnology
view channel
Inexpensive DNA Coated Electrode Paves Way for Disposable Diagnostics
Many people around the world still lack access to affordable, easy-to-use diagnostics for diseases like cancer, HIV, and influenza. Conventional sensors, while accurate, often rely on expensive equipment... Read more
New Miniature Device to Transform Testing of Blood Cancer Treatments
Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for blood cancers like leukemia, offering hope to patients when other treatments fail. However, despite its promise,... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more